Myriad Genetics reported $24.1M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US 4.58M 9.07M
Agilent A:US $ 1071M 115M
Becton, Dickinson and BDX:US $ 2558M 589M
Bio Rad Laboratories BIO:US $ 596.58M 205.73M
Bruker BRKR:US $ 723M 93.1M
Danaher DHR:US $ 3984M 267M
Exact Sciences EXAS:US $ 56.2M 1.75M
Fluidigm FLDM:US $ 74.36M 44.38M
Hologic HOLX:US $ 2375.3M 84.5M
Illumina ILMN:US $ 1289M 62M
Mettler Toledo International MTD:US 109.45M 7.5M
Myriad Genetics MYGN:US $ 24.1M 3.1M
Nanostring Technologies NSTG:US $ 126.03M 27.57M
Orasure Technologies OSUR:US $ 66.16M 4.56M
Pacific Biosciences Of California PACB:US $ 899.15M 470.58M
Perkinelmer PKI:US $ 360.86M 308.9M
Quest Diagnostics DGX:US $ 790M 78M
Quidel QDEL:US $ 379M 896.54M
Repligen RGEN:US $ 596.51M 11.87M
Thermo Fisher Scientific TMO:US $ 1888M 864M
Veracyte VCYT:US $ 153.45M 10.17M
Waters WAT:US $ 419.79M 60.28M